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CME: Spina bifida
This month’s education component continues to advise on the 
management of children born with spina bifida/myelomeningocele 
and securing long-term quality of life for these children. This is 
dependent on the challenges of their disability being recognised, 
met and overcome, so that handicap is minimised, ensuring social 
integration, education, employment and independence.
ACEIs v. ARBs: A cost-benefit analysis
Hypertension poses a financial risk to any funder/medical aid 
scheme, not least because, according to the annual report of the 
South African Council for Medical Schemes for 2010 - 2011, 
hypertension is the most prevalent chronic disease among medical 
aid members, affecting 11.7%. The medical aid industry has >8 
million beneficiaries, of whom ~1 million members will require 
treatment for hypertension. The most up-to-date South African 
Hypertension Guideline states that the choice of therapy for either an 
angiotensin converting enzyme inhibitor (ACEI) or an angiotensin 
receptor blocker (ARB) should be based on cost and tolerability. 
A health economic analysis[1] reveals that it is more cost beneficial 
to treat chronic hypertensive patients with an ACEI than with 
ARBs to prevent cardiovascular-related complications. Managed-care 
companies should continue to recommend ACEIs rather than ARBs 
in the treatment of their hypertensive patients. 
Cisplatin-induced ototoxicity
Cisplatin is administered as the first-line treatment of soft-tissue 
cancers and has a reported cure rate of up to 85%. However, 
ototoxicity, characterised by irreversible bilateral hearing loss, affects 
23 - 50% of adults and up to 60% of children. Such ototoxicity 
has been shown to be dependent on age at initiation of treatment, 
with those under 5 years and those over 40 years of age being most 
susceptible. An incidence of cisplatin-induced ototoxicity (55.1%) 
was observed in an adult population in South Africa (SA) studied 
by Whitehorn et al.,[2] of whom 62.7% experienced bilateral hearing 
loss. This study highlights the importance of regular audiological 
monitoring of patients receiving high-dose cisplatin. Adequate 
knowledge of the complication of ototoxicity on the part of clinicians 
may facilitate the prevention or amelioration of further ototoxic 
damage through administration of otoprotective agents, or a change 
of chemotherapeutic drugs. The authors call for further research 
aimed at understanding other risk factors, particularly genetic 
predictors of cisplatin-induced ototoxicity in the uniquely diverse 
SA population.
Acute porphyria: Unusual presentation 
Acute intermittent porphyria (AIP) is the most common porphyria 
affecting the nervous system. Albertyn et al.[3] describe an unusual 
presentation in a young man with AIP, a reminder that acute forms of 
porphyria should never be forgotten when confronted with a patient 
with unexplained motor neuropathy, whether or not the characteristic 
features of the acute attack are present. This patient was fortunate in 
being referred to a neurology unit where exclusion of porphyria 
is a standard practice for patients with unexplained neuropathy, 
given the very high prevalence of porphyria in the SA population. 
He, unusually, improved rapidly in response to definitive therapy 
for porphyria with haem arginate, even though neurophysiological 
studies confirmed the presence of axonal necrosis. For those with 
a research interest in neuropathophysiology, this example is an 
invitation[4] to explore the interplay of disordered haem synthesis and 
neuronal function. 
Breast cancer screening in SA
Breast cancer is a growing healthcare burden especially in the 
developing world and is the most common female cancer, accounting 
for 20% of all cancers in women in SA. The experience of breast 
cancer screening at the Tygerberg Academic Hospital, a tertiary 
referral hospital in Western Cape Province, SA,[5] indicates a high 
breast-cancer load in this urbanised population. The authors point 
out that the well documented shortage of radiologists, specifically 
breast radiologists, must not prevent the urgent establishment of 
breast centres to cater for the rapidly rising disease burden of breast 
cancer in our country while there are experienced trained surgeons, 
with a special interest in breast health, available to interpret breast 
imaging.
Risks associated with magnetic  
bead ingestion
Paediatric surgeons, Cox et al.,[6] draw attention to the risks of 
gastrointestinal (GI) injury due to ingested magnetic beads. They are 
freely available at many large retail stores and sold as an executive 
stress toy. If several are ingested, the magnets conglomerate in 
different segments of bowel, causing pressure necrosis, perforation 
and/or fistula formation anywhere along the GI tract. Symptoms 
do not occur until complications have developed, and even then, 
unless magnetic ingestion is suspected, treatment may initially be 
mistakenly expectant, as with any other foreign body. The authors 
reproduced the likely sequence of events in a laboratory setting using 
fresh, post-mortem porcine bowel as an animal model. Pressure-
induced perforation appeared extremely rapidly, replicating the 
operative findings in their cases. If magnet ingestion is suspected, 
early endoscopic or surgical retrieval is mandatory. Appropriate, 
rapid, surgical intervention is indicated, laparoscopy offering a 
minimally invasive therapeutic option.
SciELO (SA): Enhancing SA research 
I recently joined editors, publishers and researchers in São Paulo, 
Brazil, to celebrate the 15th anniversary of the Scientific Electronic 
Library Online (SciELO), which was joined by SciELO SA as its 
first African extension in 2009. SciELO SA was established by the 
Academy of Science of South Africa and is funded by the Department 
of Science and Technology. Two Health and Medical Publishing 
Group journals, the SAMJ and the South African Journal of Surgery, 
have already been accepted onto the platform.[7] Thomson Reuters: 
Intellectual Property and Science announced recently that it is 
now collaborating with the SciELO Network Portal to integrate the 
SciELO Citation Index into the Web of Knowledge. This initiative 
will bring even greater visibility and improved access to research from 
emerging countries like SA. 
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